Market News Archive

Stay updated with the latest announcements

23 Oct 2025

SONARBAINS: Appointment of Chairperson

The Company has informed that Mr. Md. Motaleb Hossain has been appointed as the Chairperson of the company.

23 Oct 2025

ICICL: Board Meeting schedule under LR 16(1)

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 28, 2025 at 5:00 PM to consider, among others, Un-audited financial statements of the Company for the Third Quarter (Q3) period ended September 30, 2025.

23 Oct 2025

BANKASIA: Confirmation of share receipt by a Sponsor

Mr. M. Syeduzzaman, a sponsor shareholder of the company, has further informed that he has received 1,084,721 shares of the company from his son Late Mohammed Irfan Syed by way of nomination.

23 Oct 2025

LANKABAFIN: Confirmation of Share Transfer by a Sponsor Director

Mr. Mohammad Abdul Moyeen, a Sponsor Director of the company, has completed his transfer of 9,650,000 shares of the company to his spouse Mrs. Iffat Huque (a general shareholder of the company) by way of gift outside the trading system of the Exchange as per declaration disseminated by DSE on 21.10.2025.

23 Oct 2025

BEACONPHAR: Price Limit Open

There will be no price limit on the trading of the shares of the Company today (23.10.2025) following its corporate declaration.

23 Oct 2025

BEACONPHAR: Dividend Declaration

The Board of Directors has recommended 21% Cash Dividend to General Shareholders (excluding Sponsors and Directors) for the year ended June 30, 2025. The Sponsors and Directors hold 92,084,615 shares out of the total 231,000,000 shares of the company and Cash Dividend payable to the General Shareholders is Tk. 291,722,309.00. Date of AGM: 23.12.2025, Time: 11:00 AM, Venue/Mode: Hybrid Platform. Record Date: 16.11.2025. (cont.)

23 Oct 2025

SUMITPOWER: Price Limit Open

There will be no price limit on the trading of the shares of the Company today (23.10.2025) following its corporate declaration.

23 Oct 2025

SUMITPOWER: Dividend Declaration

The Board of Directors has recommended 10.50% Cash Dividend for the year ended June 30, 2025. Date of AGM: 24.12.2025, Time: 11:30 AM, Venue: Digital Platform. Record Date: 11.11.2025. The Company has also reported consolidated EPS of Tk. 0.38, consolidated NAV per share of Tk. 40.57 and consolidated NOCFPS of Tk. 9.78 for the year ended June 30, 2025 as against consolidated EPS of Tk. 3.13, consolidated NAV per share of Tk. 41.44 and consolidated NOCFPS of Tk. 6.13 (cont.1)

23 Oct 2025

BIFC: Q3 Financials

(Q3 Un-audited): EPS was Tk. (0.81) for July-September 2025 as against Tk. (1.06) for July-September 2024; EPS was Tk. (3.93) for January-September 2025 as against Tk. (2.61) for January-September 2024. NOCFPS was Tk. (0.05) for January-September 2025 as against Tk. 0.12 for January-September 2024. NAV per share was Tk. (130.04) as on September 30, 2025 and Tk. (122.06) as on September 30, 2024.

23 Oct 2025

PIONEERINS: Q3 Financials

(Q3 Un-audited): EPS was Tk. 0.95 for July-September 2025 as against Tk. 0.93 for July-September 2024; EPS was Tk. 3.15 for January-September 2025 as against Tk. 3.50 for January-September 2024. NOCFPS was Tk. 1.09 for January-September 2025 as against Tk. (3.89) for January-September 2024. NAV per share was Tk. 46.71 as on September 30, 2025 and Tk. 44.65 as on December 31, 2024. NOCFPS has increased due to decrease in payment of claims during the period.

23 Oct 2025

CAPITECGBF: Q1 Financials

(Q1 Un-audited): EPU was Tk. 0.89 for July-September 2025 as against Tk. (0.01) for July-September 2024; NOCFPU was Tk. 0.37 for July-September 2025 as against Tk. (0.99) for July-September 2024. NAV per unit at market price was Tk. 10.18 as on September 30, 2025 and Tk. 9.61 as on June 30, 2025. NAV per unit at cost price was Tk. 10.66 as on September 30, 2025 and Tk. 11.04 as on June 30, 2025.

23 Oct 2025

VAMLRBBF: Q3 Financials

(Q3 Un-audited): EPU was Tk. 1.00 for July-September 2025 as against Tk. 0.55 for July-September 2024; EPU was Tk. 0.43 for January-September 2025 as against Tk. (0.72) for January-September 2024. NOCFPU was Tk. 0.25 for January-September 2025 as against Tk. 0.27 for January-September 2024. NAV per unit at market price was Tk. 9.18 as on September 30, 2025 and Tk. 8.75 as on December 31, 2024. NAV per unit at cost price was Tk. 11.39 as on September 30, 2025 and Tk. 11.25 as on December 31, 2024.

23 Oct 2025

ETL: Price Limit Open

There will be no price limit on the trading of the shares of the Company today (23.10.2025) following its corporate declaration.

23 Oct 2025

ETL: Dividend Declaration

The Board of Directors has recommended 2.50% Cash Dividend for the year ended June 30, 2025. Date of AGM: 18.12.2025, Time: 12:00 PM, Venue/Mode: Hybrid system at Nikunja Convention Hall (Level-12), 73/A, New Airport Road, Nikunja-2, Khilkhet, Dhaka-1229. Link: https://etl.bdvirtualagm.com. Record Date: 23.11.2025. (cont.)

23 Oct 2025

SHAHJABANK: Q3 Financials

(Q3 Un-audited): Consolidated EPS was Tk. 1.02 for July-September, 2025 as against Tk. 1.06 for July-September, 2024; Consolidated EPS was Tk. 3.50 for January-September, 2025 as against Tk. 3.65 for January-September, 2024. Consolidated NOCFPS was Tk. 22.97 for January-September, 2025 as against Tk. 7.84 for January-September, 2024. Consolidated NAV per share was Tk. 23.39 as on September 30, 2025 and Tk. 23.30 as on September 30, 2024. (cont.)

23 Oct 2025

PRAGATILIF: Q3 Financials

(Q3 Un-audited): As per life revenue account of the company for July to September, 2025, excess of total income over total expenses including claims (surplus) was BDT 354.75 million as against excess of total income over total expenses including claims (surplus) of BDT 15.38 million in the corresponding previous period of 2024. Whereas as per life revenue account of the company for January to September, 2025, excess of total income over (cont.)

23 Oct 2025

SQURPHARMA: Price Limit Open

There will be no price limit on the trading of the shares of the Company today (23.10.2025) following its corporate declaration.

23 Oct 2025

SQURPHARMA: Dividend Declaration and Others

The Board of Directors has recommended 120% Cash Dividend for the year ended June 30, 2025. Date of AGM: 15.12.2025, Time: 10:00 AM, Venue: Virtual Platform. Record Date: 16.11.2025. The Company has also reported Consolidated EPS of Tk. 27.04, Consolidated NAV per share of Tk. 157.88 and Consolidated NOCFPS of Tk. 19.52 for the year ended June 30, 2025 as against Tk. 23.61, Tk. 142.05 and Tk. 20.90 respectively for the year ended June 30, 2024. (cont.)

23 Oct 2025

ARGONDENIM: Price Limit Open

There will be no price limit on the trading of the shares of the Company today (23.10.2025) following its corporate declaration.

23 Oct 2025

ARGONDENIM: Dividend Declaration

The Board of Directors has recommended 10% Cash Dividend for the year ended June 30, 2025. Date of AGM: 18.12.2025, Time: 10:30 AM, Venue/Mode: Digital Platform. Link: https://argondenim.bdvirtualagm.com. Record Date: 23.11.2025. The Company has also reported EPS of Tk. 1.68, NAV per share of Tk. 24.57 and NOCFPS of Tk. 0.94 for the year ended June 30, 2025 as against Tk. 0.75, Tk. 23.89 and Tk. 3.69 respectively for the year ended June 30, 2024.

Latest Price
Quick
AI Desk
Login